Fate Therapeutics, Inc. (FATE)

1.63 +0.01 (+0.62%) USD  |  NASDAQ  |  Feb 25, 10:44
More

Fate Therapeutics Long Term Deferred Tax Assets (Quarterly)

Long Term Deferred Tax Assets (Quarterly) Chart

View Long Term Deferred Tax Assets (Quarterly) for FATE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Tax Assets (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years

View Long Term Deferred Tax Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Tax Assets (Quarterly) Benchmarks

View Long Term Deferred Tax Assets (Quarterly) Benchmarks
Start Trial
MannKind Corp. --
Vertex Pharmaceuticals, Inc. Upgrade
Ardelyx, Inc. --
ACADIA Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. Upgrade